Department of Psychiatry, University of Calgary, Calgary, Canada.
Department of Clinical Neurosciences, University of Calgary, Calgary, Canada.
J Alzheimers Dis. 2021;80(1):459-469. doi: 10.3233/JAD-201184.
Mild behavioral impairment (MBI) and subjective cognitive decline (SCD) are dementia risk states, and potentially represent neurobehavioral and neurocognitive manifestations, respectively, of early stage neurodegeneration. Both MBI and SCD predict incident cognitive decline and dementia, are associated with known dementia biomarkers, and are both represented in the NIA-AA research framework for AD in Stage 2 (preclinical disease).
To assess the associations of MBI and SCD, alone and in combination, with incident cognitive and functional decline in a population of older adults. We tested the hypothesis that MBI and SCD confer additive risk for decline.
Cognitively normal participants were followed up annually at Alzheimer's Disease Centers. Logistic regression assessed the relationship between baseline classification (MBI-SCD-, MBI-SCD+, MBI+SCD-, or MBI+SCD+) and 3-year outcome.
Of 2,769 participants (mean age=76), 1,536 were MBI-SCD-, 254 MBI-SCD+, 743 MBI+SCD-, and 236 MBI+SCD+. At 3 years, 349 (12.6%) declined to CDR >0, including 23.1% of the MBI+group, 23.5% of the SCD+group, and 30.9% of the intersection group of both MBI+and SCD+participants. Compared to SCD-MBI-, we observed an ordinal progression in risk (ORs [95% CI]): 3.61 [2.42-5.38] for MBI-SCD+ (16.5% progression), 4.76 [3.57-6.34] for MBI+SCD- (20.7%), and 8.15 [5.71-11.64] for MBI+SCD+(30.9%).
MBI and SCD together were associated with the greatest risk of decline. These complementary dementia risk syndromes can be used as simple and scalable methods to identify high-risk patients for workup or for clinical trial enrichment.
轻度行为障碍 (MBI) 和主观认知下降 (SCD) 是痴呆的风险状态,分别代表早期神经退行性变的神经行为和神经认知表现。MBI 和 SCD 均预测认知能力下降和痴呆的发生,与已知的痴呆生物标志物相关,并且在 NIA-AA 用于 AD 的研究框架中都处于 2 期(临床前疾病)。
评估 MBI 和 SCD 单独和联合对老年人群认知和功能下降的影响。我们检验了这样一个假设,即 MBI 和 SCD 共同导致下降的风险增加。
认知正常的参与者每年在阿尔茨海默病中心接受随访。逻辑回归评估了基线分类(MBI-SCD-、MBI-SCD+、MBI+SCD-或 MBI+SCD+)与 3 年结局之间的关系。
在 2769 名参与者(平均年龄 76 岁)中,1536 名是 MBI-SCD-,254 名是 MBI-SCD+,743 名是 MBI+SCD-,236 名是 MBI+SCD+。3 年后,349 名(12.6%)下降到 CDR>0,其中 MBI+组为 23.1%,SCD+组为 23.5%,MBI+和 SCD+两组的交集组为 30.9%。与 SCD-MBI-相比,我们观察到风险的有序进展(比值比[95%CI]):MBI-SCD+(16.5%进展)为 3.61[2.42-5.38],MBI+SCD-(20.7%)为 4.76[3.57-6.34],MBI+SCD+(30.9%)为 8.15[5.71-11.64]。
MBI 和 SCD 一起与下降的最大风险相关。这些互补的痴呆风险综合征可以作为简单和可扩展的方法,用于识别需要进一步检查或临床试验富集的高危患者。